Peptide Decoding
New?New to peptides?Start here →
Decoding

SHLP6_Dosage, benefits & legal status

Also known as small humanin-like peptide 6, SHLP-6, SHLP 6

Published August 24, 2026 · Updated October 4, 2026

The sibling of SHLP2, and the one reported to shut blood vessel growth down.

Metabolic & agingMitochondrial-derived peptideResearch only
DoseResearch only
FrequencyNot established
RouteUnder the skin (subcutaneous)
StatusResearch only
CycledNot established

Common vial size is what vendors typically sell, not a recommendation. Enter your own vial in the calculator.

See how this dose compares across the library →

01

What is SHLP6?

Plain language first. The technical label stays, but it never stands alone.

Overview

A cousin of SHLP2 with different reported effects, including blocking new blood vessel growth. That is the opposite of what the healing peptides sold next to it claim to do.

The technical version

SHLP6, a mitochondrial-derived peptide encoded within the MT-RNR2 16S rRNA region. Reported anti-angiogenic activity in zebrafish embryo models and antioxidant and anti-inflammatory effects in zebrafish larvae exposed to copper sulfate. No human administration study has been published.

What it's used for

A mitochondrial peptide researched for oxidative stress and cell protection.

02

How does SHLP6 work?

What it does in the body, and where.

The six SHLPs were found together and behave differently, which is the single most useful fact about them.

  1. 01
    Same origin as SHLP2, different effects
    All six come from small open reading frames in the mitochondrial 16S rRNA region. Published work notes that each shows a distinct tissue distribution and that incubating cells with different SHLPs affects viability and proliferation differently.
  2. 02
    It has been reported to block vessel formation
    In the originating patent work, SHLP6 injected into zebrafish embryos significantly inhibited blood vessel formation, and it was examined for tumour-inhibiting effects.
  3. 03
    That is the opposite of what repair peptides claim
    BPC-157, TB-500 and GHK-Cu are all sold partly on promoting new blood vessel growth. A compound reported to inhibit it is not interchangeable with them, whatever a combined product page implies.
03

What else is it used for?

Each use below carries its own evidence level. Approved means regulators have cleared it for that purpose. Investigational means it is in trials. Early research means it is being studied and is not established.

  • Protection against oxidative stressEarly research
  • Neuroprotection in zebrafish modelsEarly research
  • Anti-tumour and anti-angiogenic effectsEarly research
  • Anti-aging generally, which is the marketing framenone

The published record

Research index

11

Papers and trials about SHLP6

6 papers tagged human · 3 not reviews or lab · 0 clinical trial publications

Furthest stage reached: No clinical trial on record

Compare this against the whole library →

In animals4
In the lab1
Reviews2
Senior author shareSpread across many groups

Evidence summary

Counted from Europe PMC indexing, not read by a person; a human tag can land on reviews, commentary or lab papers; clinical trial publications is the narrower count.

SHLP6 vial rendering
Compound field notes

At a glance

Four things to know about SHLP6

01

Evidence

Research only

02

Category

Longevity and energy

03

Common vial

Varies

04

Half-life

Nothing published

04

How much, and do you cycle it?

The range, and whether you take breaks.

Research only, not established. Not established No range

No schedule has been studied for this compound in people.

Compare this against the whole library →

05

How long does it stay in the body?

The half-life, and where the figure comes from.

Nothing publishedNo figure

No half-life has been published for SHLP6.

You can compare this against the whole library to see where it sits.

06

How do I dose and price it?

Enter your vial and your dose. Pick a mix. We show the draw and the cost.

The vial holds a fixed amount of drug. Adding more water does not make more drug, it just spreads it thinner, so you draw a bigger number on the syringe for the same dose.

Your vial size (mg)
Printed on the vial.
What you paid per vial
$
Used for cost per dose only.
Your dose (mg)
Commonly referenced range: No human dose established. SHLP6 has not been administered in a published human trial; current literature is mechanistic and preclinical.No range

Choose your mix

your own mL
units · —
Enter your own volume

Measuring the water1 mL = one full 100-unit syringe.

YOUR DRAW0 / 100 units
07

How do you store it?

Before mixing, and after.

Dry powder in the freezer or fridge. Once mixed, fridge, and use within about a month.

Unmixed lyophilized SHLP6 keeps for a long time cold. Once you add water the clock starts: most reconstituted vials hold up for roughly 28 to 30 days at fridge temperature. Keep it out of light, and do not freeze it after mixing.

08

What are the side effects and cautions?

Known cautions and warnings for this compound.

Solubility, computed: 35% charged residues, 60% hydrophobic. Water usually sufficient.

A first-pass rule from peptide manufacturers' guidance. It does not account for disulfide bridges, salt form or how the powder was dried, and it predicts what should be easy rather than what will happen in your vial.

Who should avoid it

Check these before anything else.
  • Pregnancy or breastfeeding
  • Active wound healing or recovery from surgery, given the reported effect on blood vessel formation
  • Active cancer, without oncology advice
  • Anyone who wants established safety data, because none exists for this compound in humans

Stop and get help

These are emergencies. Seek care.
  • Signs of an allergic reaction, including spreading hives, facial or throat swelling, or trouble breathing
  • Redness, heat, or pus at the injection site, which can signal infection
  • Anything unusual, since there is no known safety profile to compare it against

Common effects

Expected, and usually mild.
  • Unknown. No study has recorded what this commonly causes in people
  • Redness, soreness, or a small bump at the injection site

Where this page says nothing is established, that means nobody has studied it, not that a compound is safe.

09

Is SHLP6 approved?

And where the numbers on this page come from.

No. SHLP6 is not approved for any use, anywhere. It is sold labeled for laboratory research only, and there is no legal route to buy it for human use.

  • Approval status
    Research only
  • Route
    Under the skin (subcutaneous)
  • Checked
    24 August 2026
  • Dose
    No dose has been established in people.
  • Vial size
    From what vendors typically list; not a recommendation.
  • Sources
    None traced yet.

What has happened recently

We have not yet written a full regulatory note for this compound. The status above is current as of the date shown.

Guides for this compound

Sources

No primary source has been traced for this compound yet. Treat everything on this page as unverified until one is. How we grade evidence

Beyond these, 11 records are indexed. Browse the records